NCT02779920 (GASTROPOP) is a NA clinical trial of per oral pylorotomy in Gastroparesis, sponsored by University Hospital, Limoges.

Who is sponsoring NCT02779920?

NCT02779920 is sponsored by University Hospital, Limoges.

What drugs are being tested in NCT02779920?

Interventions in NCT02779920: per oral pylorotomy.

What condition does NCT02779920 study?

NCT02779920 studies Gastroparesis.

Is NCT02779920 still recruiting?

NCT02779920 is currently completed. Last updated 16 March 2020.

Last reviewed 2020-03-16 · How we verify

NCT02779920: GASTROPOP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study.

Completed NA Last updated 16 March 2020

What this trial tests

NA trial testing per oral pylorotomy in Gastroparesis in 20 participants. Completed in 1 July 2017.

Timeline

1 April 2016

Primary endpoint
1 June 2017

1 July 2017

Quick facts

Lead sponsor	University Hospital, Limoges
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	1 April 2016
Primary completion	1 June 2017
Estimated completion	1 July 2017
Sites	1 location across France

Drugs / interventions tested

per oral pylorotomy

Conditions studied

Gastroparesis — all drugs for Gastroparesis →

Sponsor

University Hospital, Limoges

Who can join

18 and older, any sex, with Gastroparesis. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Number of technical success for endoscopic pylorotomy on the total number of gestures.
Time frame: 3 months
Technical feasibility will be the feasibility of endoscopic pylorotomy gesture by the technique of the tunnel.

Sponsor's own description

Gastroparesis is a common chronic condition, disabling the limited therapeutic resources justifying the exploration of new therapeutic possibilities. By analogy to the technique of Per Oral Endoscopic Myotomy (POEM), we believe that myotomy pyloric muscle (POP = Per Oral Pyloromyotomy) endoscopically could become a treatment of choice in the refractory gastroparesis with drug treatments by attacking the pyloric obstacle often spastic that counteracts an effective gastric emptying.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Late breaking abstracts
· 2017 · cited 2×

Verify or expand the search:

Other recruiting trials for Gastroparesis

Currently open trials in the same condition.

NCT04661215 — Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms · recruiting
NCT07104214 — Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy · recruiting
NCT07526935 — Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator · NA · active not recruiting
NCT05981300 — GpCRC Pediatric Gastroparesis Registry 2 · recruiting
NCT06580197 — The Role of AAT After Abdominal Surgery Based on RWS · recruiting

Other University Hospital, Limoges trials

Trials by the same sponsor.

NCT07407101 — Impact of Filtration on Autologous Serum Eye Drops · NA · not yet recruiting
NCT07406425 — Evaluation of Efficacy of Coconut Oil Mouth Care for Non-autonomous Hospitalised Elderly People. · NA · not yet recruiting
NCT07436780 — B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP · not yet recruiting
NCT07331298 — Apparent Diffusion Coefficient of the Intervertebral Disc in Children: Pilot Study · not yet recruiting
NCT07019818 — Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intu · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02779920 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Limoges
Last refreshed: 16 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02779920.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing